Leaders from academia and industry engage on topics from technology to ways of working.
Reduce variability in cell therapy manufacturing with standardized, automated management of apheresis product and process control strategies for mononuclear cell enrichment.
The cryogenic supply chain of cell therapies presents challenges to the delivery of cell samples. Find out about approaches to help mitigate these risks.
Building an adequate supply chain with the necessary equipment and protocols is critical for companies pursuing cell and gene therapies. Learn about our security of supply program.